Literature DB >> 17406802

[Dosimetric impact of image-guided translational isocenter correction for 3-D conformal radiotherapy of the prostate].

Hansjoerg Wertz1, Frank Lohr, Barbara Dobler, Sabine Mai, Frederik Wenz.   

Abstract

BACKGROUND AND
PURPOSE: Interfractional prostate motion during radiotherapy due to variation in rectal distension can have negative consequences. The authors investigated the dosimetric consequences of a linear translational position correction based on image guidance when a three-dimensional conformal treatment technique was used.
MATERIAL AND METHODS: Planning CTs of seven patients with empty and distended rectum were analyzed. A reference plan for the planning target volume (PTV) and the boost were calculated on the CT dataset with the empty rectum with a standard four-field technique. The treatment plan was transferred to the CT with the distended rectum for an uncorrected setup (referenced to bony anatomy) and a corrected setup after position correction of the isocenter. The dosimetric consequences were analyzed.
RESULTS: Organ motion decreased the coverage of the prostate by the 95% isodose during simulated single treatment fractions by up to -21.0 percentage points (%-p; boost plan) and by up to -14.9%-p for the seminal vesicles (PTV plan). The mean rectum dose increased by up to 18.3%-p (PTV plan). Linear translational correction (mean 6.4 +/- 3.4 mm, maximum 10.8 mm) increased the coverage of the prostate by the 95% isodose by up to 12.7%-p (boost plan), while the mean rectum dose was reduced by up to -8.9%-p (PTV plan). For the complete treatment a reduction of complication probability of the rectum of approximately 5%-p was calculated.
CONCLUSION: The use of an image guidance system with linear translational correction can improve radiation treatment accuracy for prostate cancer, if geometric changes are within certain limits.

Entities:  

Mesh:

Year:  2007        PMID: 17406802     DOI: 10.1007/s00066-007-1619-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  14 in total

1.  Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple Fiducials.

Authors:  Frederick Marc Köhler; Judit Boda-Heggemann; Beate Küpper; Dirk Wolff; Hansjörg Wertz; Frank Lohr; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

Review 2.  Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Authors:  Anna O Simeonova; Katharina Fleckenstein; Hansjörg Wertz; Anian Frauenfeld; Judit Boda-Heggemann; Frank Lohr; Frederik Wenz
Journal:  Transl Lung Cancer Res       Date:  2012-03

3.  Effect of a prostaglandin--given rectally for prevention of radiation-induced acute proctitis--on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study.

Authors:  Tereza Kertesz; Markus K A Herrmann; Antonia Zapf; Hans Christiansen; Robert M Hermann; Olivier Pradier; Heinz Schmidberger; Clemens F Hess; Andrea Hille
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

4.  Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy.

Authors:  Jörn Kalz; Florian Sterzing; Kai Schubert; Gabriele Sroka-Perez; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

5.  Monitoring of tumor oxygenation changes in head-and-neck carcinoma patients breathing a hyperoxic hypercapnic gas mixture with a noninvasive MRI technique.

Authors:  Markus Kotas; Peter Schmitt; Peter M Jakob; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

6.  Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer.

Authors:  Buelent Polat; Iris Guenther; Juergen Wilbert; Joachim Goebel; Reinhart A Sweeney; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

7.  Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.

Authors:  Markus Bohrer; Peter Schröder; Grit Welzel; Hansjörg Wertz; Frank Lohr; Frederik Wenz; Sabine Kathrin Mai
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

8.  Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion.

Authors:  Michael Pinkawa; Martin Pursch-Lee; Branka Asadpour; Bernd Gagel; Marc D Piroth; Jens Klotz; Sandra Nussen; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

9.  IMRT of prostate cancer: a comparison of fluence optimization with sequential segmentation and direct step-and-shoot optimization.

Authors:  Marius Treutwein; Matthias Hipp; Oliver Kölbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

10.  The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment.

Authors:  Markus Karl Alfred Herrmann; Tammo Gsänger; Arne Strauss; Tereza Kertesz; Hendrik A Wolff; Hans Christiansen; Hilke Vorwerk; Clemens Friedrich Hess; Andrea Hille
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.